Goldman Sachs Group Inc. Grows Holdings in Corteva, Inc. $CTVA

Goldman Sachs Group Inc. raised its position in Corteva, Inc. (NYSE:CTVA) by 26.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,531,726 shares of the company’s stock after buying an additional 1,150,926 shares during the period. Goldman Sachs Group Inc. owned about 0.82% of Corteva worth $370,792,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. JPL Wealth Management LLC purchased a new position in Corteva in the third quarter valued at $25,000. Redmont Wealth Advisors LLC purchased a new stake in shares of Corteva during the third quarter worth about $29,000. Jackson Grant Investment Advisers Inc. increased its stake in shares of Corteva by 90.6% during the third quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares in the last quarter. Basepoint Wealth LLC purchased a new stake in shares of Corteva during the fourth quarter worth about $30,000. Finally, Measured Wealth Private Client Group LLC purchased a new stake in shares of Corteva during the third quarter worth about $33,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Down 0.5%

Shares of NYSE CTVA opened at $77.06 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.63. The stock has a market cap of $51.54 billion, a PE ratio of 45.33, a P/E/G ratio of 2.37 and a beta of 0.57. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average of $81.17 and a 200 day moving average of $74.94.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. Corteva’s revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s payout ratio is presently 42.35%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the stock. Morgan Stanley boosted their target price on shares of Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 28th. Rothschild & Co Redburn boosted their target price on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Wall Street Zen cut shares of Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Mizuho boosted their target price on shares of Corteva from $82.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 15th. Finally, Citigroup boosted their target price on shares of Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research note on Thursday, May 7th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $88.67.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.